Smarttech247 holding a very strong position and looking at expanding operations (LON:S247) 23 January 2024
Time Finance CEO discusses progress, outlook, and key differentiators in exclusive interview 16 January 2024
Diversified Energy Company analysts share its compelling investment case (LON: DEC) 11 September 2023
Diversified Energy Company ‘to benefit from US natural gas market recovery’ says Tim Hurst-Brown, Tennyson 8 September 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Smarttech247 holding a very strong position and looking at expanding operations (LON:S247) 23 January 2024
Time Finance CEO discusses progress, outlook, and key differentiators in exclusive interview 16 January 2024
Diversified Energy Company analysts share its compelling investment case (LON: DEC) 11 September 2023
Diversified Energy Company ‘to benefit from US natural gas market recovery’ says Tim Hurst-Brown, Tennyson 8 September 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Prothena Corporation plc (PRTA) Stock Analysis: Exploring 116.77% Potential Upside in Biotechnology 19 December 2025
Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Visionary with a 607.85% Potential Upside 19 December 2025
Oric Pharmaceuticals (ORIC) Stock Analysis: Exploring a 157% Upside Potential in the Biotech Arena 19 December 2025
Inventiva S.A. (IVA): Biotech Stock with a 265% Potential Upside – An Investor’s Outlook 19 December 2025
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a 76% Potential Upside in CNS Therapeutics 19 December 2025
Personalis, Inc. (PSNL) Investor Outlook: Unpacking the 38.80% Potential Upside in Cancer Genomics 19 December 2025
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unveiling a 46.94% Potential Upside for Investors 19 December 2025
MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a Potential 104% Upside for Investors 19 December 2025
Zevra Therapeutics, Inc. (ZVRA): A Promising Biotech with 178% Potential Upside and Strong Analyst Confidence 19 December 2025
Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 111% Potential Upside in the Healthcare Sector 19 December 2025
Definitive Healthcare Corp. (DH) Stock Report: Evaluating a 45% Potential Upside Amidst Sector Challenges 19 December 2025
Tilray Brands, Inc. (TLRY) Stock Analysis: Potential Upside Amidst Healthcare Sector Challenges 19 December 2025
Celcuity Inc. (CELC) Stock Analysis: Exploring a Potential 11% Upside in Biotechnology 19 December 2025
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A 29.45% Upside Amidst Biotech Challenges 19 December 2025
Surmodics, Inc. (SRDX) Stock Report: Navigating Healthcare Innovation Amidst Financial Challenges 19 December 2025
Abivax SA (ABVX): Investor Outlook Reveals 27.89% Potential Upside Amid Robust Buy Ratings 19 December 2025
Precigen, Inc. (PGEN) Stock Analysis: Exploring a 103.84% Upside Potential in the Booming Biotech Sector 19 December 2025
Tourmaline Bio, Inc. (TRML) Stock Analysis: A Biotech Contender with a Breakthrough Focus 19 December 2025
Cizzle Biotechnology programme with US firm Bio-Techne takes major step forward (VIDEO) 20 September 2023
Real Estate Credit Investments – why commercial property worries do not apply to RECI (VIDEO) 12 September 2023
Smarttech247 holding a very strong position and looking at expanding operations (LON:S247) 23 January 2024
Time Finance CEO discusses progress, outlook, and key differentiators in exclusive interview 16 January 2024
Diversified Energy Company analysts share its compelling investment case (LON: DEC) 11 September 2023
Diversified Energy Company ‘to benefit from US natural gas market recovery’ says Tim Hurst-Brown, Tennyson 8 September 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
